bromodeoxyuridine has been researched along with bq 123 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, MA; Mikhailidis, DP; Morgan, RJ; Mumtaz, FH; Shukla, N; Stansby, G; Sullivan, ME; Thompson, CS | 1 |
| Khan, MA; Mikhailidis, DP; Morgan, RJ; Mumtaz, FH; Shukla, N; Thompson, CS | 1 |
2 other study(ies) available for bromodeoxyuridine and bq 123
| Article | Year |
|---|---|
Inhibition of diabetic bladder smooth muscle cell proliferation by endothelin receptor antagonists.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelin Receptor Antagonists; Male; Muscle, Smooth; Oligopeptides; Peptides, Cyclic; Piperidines; Rabbits; Receptor, Endothelin A; Receptor, Endothelin B; Reference Values; Urinary Bladder | 2000 |
Endothelin-1 and urinary bladder hyperplasia following partial bladder outlet obstruction.
Topics: Animals; Bromodeoxyuridine; Endothelin-1; Hyperplasia; Male; Oligopeptides; Peptides, Cyclic; Piperidines; Rabbits; Urinary Bladder; Urinary Bladder Neck Obstruction | 2000 |